Adrenolipoma overview: Difference between revisions

Jump to navigation Jump to search
Line 62: Line 62:


==Causes==
==Causes==
There are no established causes for adrenolipoma.
There are no established causes for adrenolipoma. However, Adrenal myelolipoma is often associated with conditions which can be considered as adrenal stimulants such as
* Cushing's disease
* Obesity
* Hyperlipidemia
* Hypertension
* Diabetes
* Stressful lifestyle
* Unbalanced diet
 
==Differentiating Adrenolipoma from other Disease==
==Differentiating Adrenolipoma from other Disease==
Adrenolipoma must be differentiated from [[retroperitoneal liposarcoma]], [[Teratoma|adrenal teratoma]], and [[adrenocortical carcinoma]].
Adrenolipoma must be differentiated from [[retroperitoneal liposarcoma]], [[Teratoma|adrenal teratoma]], and [[adrenocortical carcinoma]].

Revision as of 20:01, 22 April 2019

Adrenolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenolipoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenolipoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenolipoma overview

CDC on Adrenolipoma overview

Adrenolipoma overview in the news

Blogs on Adrenolipoma overview

Directions to Hospitals Treating Adrenolipoma

Risk calculators and risk factors for Adrenolipoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

Adrenolipomas are rare benign neoplasms that histologically consist of fat and bone marrow in varying proportions. In general, they are small, unilateral, and hormonally inactive. They are rich in adipose tissue and hematopoietic elements. Most lesions are small and asymptomatic. Adrenolipomas are usually detected incidentally in autopsy or by imaging studies performed for other reasons. Most tumors are unilateral, they show no predilection to one peculiar side. Symptoms of adrenolipoma include abdominal pain, haematuria, and abdominal fullness. Surgery is the mainstay of treatment.

Historical Perspective

Adrenolipoma was first discovered by Gierke in 1905.[1]

Classification

Myelolipomas are classified into 4 type based on their clinicopathologic patterns:

  • Isolated adrenal myelolipoma
  • Adrenal myelolipoma with acute hemorrhage
  • Extra-adrenal myelolipoma
  • Myelolipoma associated with other adrenal diseases.
Clinicopathologic patterns Description Symptoms
Isolated Adrenal Myelolipoma
  • Myelolipomas occurring in an otherwise normal adrenal gland
  • Most common pattern of presentation
  • Asymptomatic
  • Incidentally identified
Adrenal Myelolipoma with Acute Hemorrhage
  • Isolated larger lesions (typically over 4 cm in size)
  • Retroperitoneal hemorrhage
Extra-adrenal Myelolipoma
  • Myelolipomas occurring outside the adrenal gland
    • Retroperitoneum (presacral or perirenal)
  • Patients usually have no endocrine disorder or acute haemorrhage.
Adrenal Myelolipoma with Associated Adrenal Disease
  • Associated with endorcrine disorder
    • Hypercortisolism (Cushing syndrome) and 21-hydroxylase deficiency with adrenal hyperplasia
  • Reported to present with an underlying endocrine disorder.

Pathophysiology

  • Myelolipomas are usually less than 4 cm in size occasionally measuring more than 10 cm in size.
  • Extra-adrenal sites for myelolipomas include the retroperitoneum, thorax, and pelvis.
  • Usually unilateral however they can also involve both adrenals.
  • One hypothesis suggests that stimuli, such as necrosis, inflammation, infection, or stress could cause adrenocortical cell metaplasia
  • If chronically present these stimulants lead to the development of neoplasms.
  • This hypothesis is supported by the increased incidence of the lesion in the advanced years of life.
  • On gross pathologic examination, a cut section of a myelolipoma has a variegated appearance consisting of bright yellow areas of fat, dark red areas of hematopoietic myeloid tissue, and areas with intermixed red and yellow components.
  • On histopathologic examination, myelolipomas are predominantly composed of fatty areas with interspersed hematopoietic tissue components.
    • These fatty elements and hematopoietic areas may be clearly separated, or they are often intermixed.
    • Tissue analysis often reveals a variable amalgamation of myeloid and erythroid cells, megakaryocytes, and occasionally lymphocytes.
    • In an isolated adrenal myelolipoma, a peripheral rim of normal adrenal cortical tissue can be commonly identified distinctly from the mass.
    • Rarely the myelolipomas can contain osteoid tissue in addition to the myeloid tissue.
    • The hemorrhagic areas may be partly replaced by fibrotic tissue or may undergo calcification

Causes

There are no established causes for adrenolipoma. However, Adrenal myelolipoma is often associated with conditions which can be considered as adrenal stimulants such as

  • Cushing's disease
  • Obesity
  • Hyperlipidemia
  • Hypertension
  • Diabetes
  • Stressful lifestyle
  • Unbalanced diet

Differentiating Adrenolipoma from other Disease

Adrenolipoma must be differentiated from retroperitoneal liposarcoma, adrenal teratoma, and adrenocortical carcinoma.

Epidemiology and Demographics

  • The incidence of adrenolipoma is approximately 0.8-4 per 100,000 individuals worldwide.
  • Adrenolipoma affects men and women equally.[1]
  • Adrenolipomas are usually recognized in adults, either incidentally at ultrasound or computed topography or may present with vague abdominal symptoms if complicated by hemorrhage.

Risk Factors

There are no established risk factors.

Screening

There is insufficient evidence to recommend routine screening for adrenolipoma.

Complications

Common complications of adrenolipoma include Cushing syndrome, Conn syndrome, congenital adrenal hyperplasia and retroperitoneal haemorrhage.[1]

Diagnosis

History and Symptoms

Symptoms of adrenolipoma include abdominal pain, haematuria, and abdominal fullness.

Laboratory Findings

There are no associated laboratory findings among the majority of patients with adrenolipoma.

Abdominal X-Ray

There are no abdominal X-ray findings associated with adrenolipoma.

CT

Abdominal CT scan may be helpful in the diagnosis of adrenolipoma.

MRI

Abdominals MRI may be helpful in the diagnosis of adrenolipoma.

Ultrasonography

On ultrasound, adrenolipoma is characterized by heterogenous mass of mixed hyper- and hypoechoic components.

Other Diagnostic Studies

Other diagnostic studies for adrenolipoma include fine needle aspiration and fluorodeoxyglucose uptake (FDG).[1]

Treatment

Medical Therapy

There is no treatment for adrenolipoma; the mainstay of therapy is supportive care.

Surgery

Surgery is the mainstay of treatment of large adrenolipomas.

Primary Prevention

There are no preventive measurements available for adrenolipoma.

References

Template:WikiDoc Sources